Font Size: a A A
Keyword [EZH2]
Result: 181 - 200 | Page: 10 of 10
181. MiR-340 Inhibits Triple-negative Breast Cancer Progression By Reversing EZH2 Mediated MiRNAs Dysregulated Expressions
182. The Study Of Inhibiting The Invasion-metastasis Cascade Of HNSCC By Targeting EZH2/STAT3/VEGFR2 Axis
183. Effect Of Histone Methylation Modification Related Proteins On ISO-induced Cardiac Hypertrophy
184. The Fuction And Mechanism Of MiR-26a In Tumor-infiltrating CD8~+T Cells
185. Studies On The Association Of EZH2 Expression With Its Clinicopathological Features?prognosis And Biological Behaviors In Non-small Cell Lung Carcinoma
186. Clinicopathological Study Of EZH2 Protein And MRNA Expression In Invasive Pituitary Adenomas
187. Study On The Intervention Effect Of Arsenic Trioxide On The Expression Of EZH2 And MRNA In Acute Myeloid Leukemia U937 Cells
188. A Preliminary Study Of Nobiletin Improve The Sensitivity Of Prostate Cancer PC3 Cells To Che Motherapy And Its Mechanism
189. EZH2 Induces The Expression Of MiR-1301 As A Negative Feedback Control Mechanism In Triple Negative Breast Cancer
190. Study On Up Of MiR-101 Inhibiting Proliferation And Invasion Of Retinoblastoma
191. The Role Of EZH2 For The Proliferation Of ER Positive Breast Cancer Cells And The Intervention Effect Of Resveratrol
192. Effect And Mechanism Of EZH2 And HMGA1 On Glioblastoma
193. Targeting Histone Lysine Methyltransferase EZH2 Eliminates Leukemia Stem Cells And Its Underlying Mechanism In Chronic Myelogenous Leukemia
194. LncAPC Drives Wnt/?-catenin Activation And Liver TIC Self-Renewal Through APC Transcriptional Inhibition
195. MiR-130a Inhibits Cell Growth And Epithelial To Mesenchymal Transition By Repression Of HMGB2 In Glioma
196. Clinical Implications And Molecular Mechanisms Of Biological Behaviors Related Biomarkers EZH2 And SPRR1A In Leukemia And Lymphoma
197. EZH2 Suppresses NK Cell Anti-tumor Activity Through Interaction With Aiolos
198. Study On The Biological Behavior Of LncRNA-ANCR In Regulating Osteosarcoma Cells And Its Related Mechanism
199. EZH2 Enhances Ovarian Cancer Cisplatin Resistance By Mediating Cisplatin Induced CTR1 Degradation
200. PDGFR-? Signaling Regulates Cardiomyocyte Proliferation And Myocardial Regeneration
  <<First  <Prev  Next>  Last>>  Jump to